0001192482-19-000050.txt : 20190128
0001192482-19-000050.hdr.sgml : 20190128
20190128162002
ACCESSION NUMBER: 0001192482-19-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190124
FILED AS OF DATE: 20190128
DATE AS OF CHANGE: 20190128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sebree Terri B
CENTRAL INDEX KEY: 0001297912
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37526
FILM NUMBER: 19545690
MAIL ADDRESS:
STREET 1: ZYNERBA PHARMACEUTICALS, INC.
STREET 2: 80 W. LANCASTER AVENUE, SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zynerba Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001621443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260389433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 W. LANCASTER AVENUE
STREET 2: SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
BUSINESS PHONE: 484-581-7505
MAIL ADDRESS:
STREET 1: 80 W. LANCASTER AVENUE
STREET 2: SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
FORMER COMPANY:
FORMER CONFORMED NAME: Zynerba Pharmeceuticals, Inc.
DATE OF NAME CHANGE: 20141003
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-01-24
0001621443
Zynerba Pharmaceuticals, Inc.
ZYNE
0001297912
Sebree Terri B
C/O ZYNERBA PHARMACEUTICALS, INC.
80 W. LANCASTER AVENUE, SUITE 300
DEVON
PA
19333
0
1
0
0
President
Common Stock
2019-01-24
4
A
0
3600
0
A
186146
D
Stock Option (right to buy)
3.65
2019-01-24
4
A
0
120000
0
A
2029-01-24
Common Stock
120000
120000
D
Shares of restricted stock which vest 50% on the first anniversary of the grant date and 50% on the second anniversary of the grant date, subject to continued employment with the Company.
The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company.
/s/ Suzanne M. Hanlon, Attorney-in-Fact
2019-01-28